Ditchcarbon
  • Customers
  1. Organizations
  2. Vanda Pharmaceuticals Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Vanda Pharmaceuticals Inc.

Company website

Vanda Pharmaceuticals Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2003, the company has made significant strides in developing innovative therapies for patients with unmet medical needs, particularly in the fields of central nervous system disorders and sleep disorders. Vanda's core products, including the FDA-approved medications Fanapt and Hetlioz, are distinguished by their unique mechanisms of action and targeted therapeutic approaches. The company has established a strong market position, recognised for its commitment to advancing treatment options and improving patient outcomes. With a focus on research and development, Vanda continues to explore new avenues for growth and innovation in the pharmaceutical landscape.

DitchCarbon Score

How does Vanda Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Vanda Pharmaceuticals Inc.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

Vanda Pharmaceuticals Inc.'s reported carbon emissions

Vanda Pharmaceuticals Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company. As a result, Vanda Pharmaceuticals has not established any significant climate commitments or initiatives aimed at reducing its carbon footprint. The lack of emissions data and reduction strategies suggests that the company may still be in the early stages of developing a comprehensive climate action plan. In the broader context of the pharmaceutical industry, many companies are increasingly focusing on sustainability and carbon reduction, often setting science-based targets to align with global climate goals. However, without specific commitments or data from Vanda Pharmaceuticals, it remains unclear how the company plans to address its environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Vanda Pharmaceuticals Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Vanda Pharmaceuticals Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Vanda Pharmaceuticals Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Meda Pharmaceuticals Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Bayer HealthCare Pharmaceuticals Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Teva Pharmaceuticals USA, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

ANI Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Noven Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy